BREAKING NEWS

BREAKING NEWS

Roche touts study data as eye disease market primed for shake-up

Roche touts study data as eye disease market primed for shake-up
FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel January 30, 2014. REUTERS/Ruben Sprich/File Photo -
Copyright
Ruben Sprich(Reuters)
Text size Aa Aa

ZURICH (Reuters) - Swiss drugmaker Roche <ROG.S> on Monday touted data for a new drug against a blindness-causing eye disease that hits millions of older people, the latest sign this multi-billion-dollar market is primed for disruption.

Roche's experimental faricimab, a bispecific antibody, showed potential for extended durability in use against the disease neovascular age-related macular degeneration, it said in a statement.

(Reporting by John Miller; Editing by Maria Sheahan)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.